pp2a (Cell Signaling Technology Inc)
Structured Review
Pp2a, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 204 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pp2a/PP2A+A+Subunit+Antibody/pm41827042-71-15-16
Average 95 stars, based on 204 article reviews
Images
Related Articles
Blocking Assay:Article Title: Reduction of Neuroinflammation as a Common Mechanism of Action of Anorexigenic and Orexigenic Peptide Analogues in the Triple Transgenic Mouse Model of Alzheimer´s Disease. Article Snippet: .. The following primary antibodies were diluted 1: 1000 in casein blocking buffer with 0.01% Tween-20: glycogen-synthase kinase 3β (GSK-3β), pGSK-3β [Ser9], IκB kinase β (IKKβ, Cell Signaling Technology, Danvers, Massachusetts, USA), pIKK α/β [Ser176/180] (Cell Signaling Technology, Danvers, Massachusetts, USA), nuclear factor κB (NFκB, Cell Signaling Technology, Danvers, Massachusetts, USA), Incubation:Article Title: Pyr3 inhibits cell viability and PKCα activity to suppress migration in human bladder cancer cells. Article Snippet: Bladder cancer, more prevalent in men, has high recurrence rates in non-muscle-invasive forms and is highly lethal upon metastasis in muscle-invasive cases.. Transient receptor potential canonical channels (TRPCs), specifically TRPC3, play a role in calcium signaling, influencing cancer cell behavior.. This study examines the effects of Pyr3, a TRPC3 inhibitor, and TRPC3 knockdown on both muscle-invasive (T24) and non-muscle-invasive (RT4) bladder cancer cells. |

